AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,892,000 | +126.9% | 65,035 | +6.5% | 0.01% | +133.3% |
| Q3 2019 | $1,715,000 | -24.5% | 61,051 | +1.8% | 0.00% | -25.0% |
| Q2 2019 | $2,271,000 | +17.9% | 59,981 | +21.5% | 0.00% | 0.0% |
| Q1 2019 | $1,926,000 | +95.7% | 49,348 | +6.9% | 0.00% | +100.0% |
| Q4 2018 | $984,000 | -15.8% | 46,150 | +56.3% | 0.00% | 0.0% |
| Q3 2018 | $1,169,000 | -1.7% | 29,518 | -5.1% | 0.00% | 0.0% |
| Q2 2018 | $1,189,000 | +132.7% | 31,109 | +82.9% | 0.00% | +100.0% |
| Q1 2018 | $511,000 | +22.5% | 17,008 | +27.4% | 0.00% | 0.0% |
| Q4 2017 | $417,000 | +11.5% | 13,351 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $374,000 | +48.4% | 13,351 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $252,000 | – | 13,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |